IL326205A - Intermediates for synthesizing exatecan mesylate - Google Patents
Intermediates for synthesizing exatecan mesylateInfo
- Publication number
- IL326205A IL326205A IL326205A IL32620526A IL326205A IL 326205 A IL326205 A IL 326205A IL 326205 A IL326205 A IL 326205A IL 32620526 A IL32620526 A IL 32620526A IL 326205 A IL326205 A IL 326205A
- Authority
- IL
- Israel
- Prior art keywords
- intermediates
- synthesizing
- exatecan mesylate
- exatecan
- mesylate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363516024P | 2023-07-27 | 2023-07-27 | |
| PCT/US2024/039606 WO2025024697A1 (en) | 2023-07-27 | 2024-07-25 | Intermediates for synthesizing exatecan mesylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326205A true IL326205A (en) | 2026-03-01 |
Family
ID=92295905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326205A IL326205A (en) | 2023-07-27 | 2024-07-25 | Intermediates for synthesizing exatecan mesylate |
Country Status (4)
| Country | Link |
|---|---|
| KR (1) | KR20260048597A (en) |
| CN (1) | CN121909178A (en) |
| IL (1) | IL326205A (en) |
| WO (1) | WO2025024697A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020003466B1 (en) | 2017-08-31 | 2023-12-12 | Daiichi Sankyo Company, Limited | COMPOST PRODUCTION METHODS, AND, COMPOST |
| US12252502B2 (en) * | 2019-01-11 | 2025-03-18 | Cj Cheiljedang Corporation | L-glufosinate intermediate and L-glufosinate preparation method |
| CN111470998B (en) | 2020-06-28 | 2020-09-25 | 上海皓元生物医药科技有限公司 | Intermediate for synthesizing camptothecin derivative and preparation method and application thereof |
| CN115724758B (en) * | 2021-08-24 | 2024-12-27 | 杭州中美华东制药有限公司 | Camptothecin derivative intermediate, synthesis method thereof and method for synthesizing camptothecin derivative by using intermediate |
| CN118119594A (en) * | 2021-10-26 | 2024-05-31 | 上海弼领生物技术有限公司 | A camptothecin derivative intermediate, preparation method and use thereof |
-
2024
- 2024-07-25 IL IL326205A patent/IL326205A/en unknown
- 2024-07-25 KR KR1020267006107A patent/KR20260048597A/en active Pending
- 2024-07-25 CN CN202480061426.XA patent/CN121909178A/en active Pending
- 2024-07-25 WO PCT/US2024/039606 patent/WO2025024697A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN121909178A (en) | 2026-04-21 |
| WO2025024697A1 (en) | 2025-01-30 |
| KR20260048597A (en) | 2026-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202212641D0 (en) | Novel compounds | |
| GB202202921D0 (en) | Novel compounds | |
| GB202300833D0 (en) | Novel compounds | |
| IL326205A (en) | Intermediates for synthesizing exatecan mesylate | |
| CA3300003A1 (en) | Intermediates for synthesizing exatecan mesylate | |
| GB2616849B (en) | Improved synthesis | |
| GB202307426D0 (en) | Novel compounds | |
| GB202302686D0 (en) | Novel compounds | |
| GB202206054D0 (en) | Novel Compounds | |
| GB202104417D0 (en) | Novel intermediates | |
| IL294503B1 (en) | Polymorphs of elafibranor | |
| GB202510799D0 (en) | Polymorphs | |
| GB202300923D0 (en) | Novel polymorphic forms of savolitinib | |
| IL326732A (en) | Synthesis of lanifibranor intermediate | |
| GB202316971D0 (en) | Novel compounds | |
| GB202315015D0 (en) | Novel compounds | |
| GB202310218D0 (en) | Novel compounds | |
| GB202310221D0 (en) | Novel compounds | |
| GB202308148D0 (en) | Novel compounds | |
| GB202308147D0 (en) | Novel compounds | |
| GB202307972D0 (en) | Novel compounds | |
| GB202307797D0 (en) | Novel compounds | |
| GB202307427D0 (en) | Novel compounds | |
| GB202305812D0 (en) | Novel compounds | |
| GB202305813D0 (en) | Novel compounds |